Table 5 Clinical outcomes in patients with LVA and apical segment akinesis according to anticoagulant use or not

From: Clinical characteristics and prognostic importance of anticoagulant use in ischemic left ventricular aneurysm: a retrospective cohort study

 

Overall N = 437

With anticoagulant use N = 128

Without anticoagulant use N = 309

P-value

NACEs

70 (16.0%)

10 (7.8%)

60 (19.4%)

0.002

All-cause mortality

19 (4.3%)

5 (3.9%)

14 (4.5%)

1.000

 Cardiovascular mortality

11 (2.5%)

2 (1.6%)

9 (2.9%)

0.521

Systemic embolism events

47 (10.8%)

5 (3.9%)

42 (13.6%)

0.002

 Stroke/TIA

39 (8.9%)

3 (2.3%)

36 (11.7%)

0.001

 Embolization

15 (3.4%)

3 (2.3%)

12 (3.9%)

0.569

Major bleeding events

20 (4.6%)

4 (3.1%)

16 (5.2%)

0.455

  1. All statistical tests were two-sided at a significance level of 0.05.
  2. NACEs net adverse clinical events, TIA transient ischemic attack.
Back to article page